laurent coudeville
laurent coudeville
Adresse e-mail validée de sanofipasteur.com
Titre
Citée par
Citée par
Année
Estimating the global burden of endemic canine rabies
K Hampson, L Coudeville, T Lembo, M Sambo, A Kieffer, M Attlan, ...
PLoS neglected tropical diseases 9 (4), e0003709, 2015
10992015
Economic impact of dengue illness in the Americas
DS Shepard, L Coudeville, YA Halasa, B Zambrano, GH Dayan
The American journal of tropical medicine and hygiene 84 (2), 200, 2011
5252011
Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model
L Coudeville, F Bailleux, B Riche, F Megas, P Andre, R Ecochard
BMC medical research methodology 10 (1), 1-11, 2010
2742010
Health economics of dengue: a systematic literature review and expert panel's assessment
ME Beatty, P Beutels, MI Meltzer, DS Shepard, J Hombach, R Hutubessy, ...
The American journal of tropical medicine and hygiene 84 (3), 473-488, 2011
1882011
The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study
S Flasche, M Jit, I Rodríguez-Barraquer, L Coudeville, M Recker, K Koelle, ...
PLoS medicine 13 (11), e1002181, 2016
1512016
Strategies for containing a global influenza pandemic
A Flahault, E Vergu, L Coudeville, RF Grais
Vaccine 24 (44-46), 6751-6755, 2006
1212006
The value of varicella vaccination in healthy children: cost–benefit analysis of the situation in France
L Coudeville, F Paree, T Lebrun, J Sailly
Vaccine 17 (2), 142-151, 1999
971999
Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies
L Coudeville, A Van Rie, P Andre
Epidemiology & Infection 136 (5), 604-620, 2008
912008
Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects
L Coudeville, A Van Rie, D Getsios, JJ Caro, P Crepey, VH Nguyen
PloS one 4 (7), e6284, 2009
822009
Use of multiple data sources to estimate the economic cost of dengue illness in Malaysia
DS Shepard, EA Undurraga, RS Lees, Y Halasa, LCS Lum, CW Ng
The American journal of tropical medicine and hygiene 87 (5), 796, 2012
782012
Transmission dynamics of the four dengue serotypes in southern Vietnam and the potential impact of vaccination
L Coudeville, GP Garnett
PloS one 7 (12), e51244, 2012
712012
The economic value of childhood varicella vaccination in France and Germany
L Coudeville, A Brunot, TD Szucs, B Dervaux
Value in health 8 (3), 209-222, 2005
662005
Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular …
F Bailleux, L Coudeville, A Kolenc-Saban, J Bevilacqua, L Barreto, ...
Vaccine 26 (31), 3903-3908, 2008
622008
The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health–economic analysis
E Lopez, R Debbag, L Coudeville, F Baron-Papillon, J Armoni
Journal of gastroenterology 42 (2), 152-160, 2007
562007
Varicella vaccination in Italy
L Coudeville, A Brunot, C Giaquinto, C Lucioni, B Dervaux
Pharmacoeconomics 22 (13), 839-855, 2004
562004
Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies
L Coudeville, N Baurin, E Vergu
Vaccine 34 (50), 6417-6425, 2016
552016
Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia
I Dorigatti, R Aguas, CA Donnelly, B Guy, L Coudeville, N Jackson, ...
Vaccine 33 (31), 3746-3751, 2015
452015
Tetravalent dengue vaccine reduces symptomatic and asymptomatic dengue virus infections in healthy children and adolescents aged 2–16 years in Asia and Latin America
G Olivera-Botello, L Coudeville, K Fanouillere, B Guy, L Chambonneau, ...
The Journal of infectious diseases 214 (7), 994-1000, 2016
442016
Cost-effectiveness of dengue vaccination in ten endemic countries
W Zeng, YA Halasa-Rappel, N Baurin, L Coudeville, DS Shepard
Vaccine 36 (3), 413-420, 2018
412018
A recombinant live attenuated tetravalent vaccine for the prevention of dengue
B Guy, F Noriega, RL Ochiai, M L’azou, V Delore, A Skipetrova, F Verdier, ...
Expert review of vaccines 16 (7), 671-684, 2017
412017
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20